242 related articles for article (PubMed ID: 10078969)
1. Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies.
Naef R; Suter U
Neurobiol Dis; 1999 Feb; 6(1):1-14. PubMed ID: 10078969
[TBL] [Abstract][Full Text] [Related]
2. Many facets of the peripheral myelin protein PMP22 in myelination and disease.
Naef R; Suter U
Microsc Res Tech; 1998 Jun; 41(5):359-71. PubMed ID: 9672419
[TBL] [Abstract][Full Text] [Related]
3. Regulation of myelin-specific gene expression. Relevance to CMT1.
Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a recessive PMP22 point mutation in Charcot-Marie-Tooth disease type 1A.
Roa BB; Garcia CA; Pentao L; Killian JM; Trask BJ; Suter U; Snipes GJ; Ortiz-Lopez R; Shooter EM; Patel PI; Lupski JR
Nat Genet; 1993 Oct; 5(2):189-94. PubMed ID: 8252046
[TBL] [Abstract][Full Text] [Related]
5. Genetic basis of inherited peripheral neuropathies.
Suter U; Patel PI
Hum Mutat; 1994; 3(2):95-102. PubMed ID: 7515304
[TBL] [Abstract][Full Text] [Related]
6. Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutation.
Giambonini-Brugnoli G; Buchstaller J; Sommer L; Suter U; Mantei N
Neurobiol Dis; 2005 Apr; 18(3):656-68. PubMed ID: 15755691
[TBL] [Abstract][Full Text] [Related]
7. Novel mutations in the Charcot-Marie-Tooth disease genes PMP22, MPZ, and GJB1.
Huehne K; Benes V; Thiel C; Kraus C; Kress W; Hoeltzenbein M; Ploner CJ; Kotzian J; Reis A; Rott HD; Rautenstrauss BW
Hum Mutat; 2003 Jan; 21(1):100. PubMed ID: 12497641
[TBL] [Abstract][Full Text] [Related]
8. Molecular alterations resulting from frameshift mutations in peripheral myelin protein 22: implications for neuropathy severity.
Johnson JS; Roux KJ; Fletcher BS; Fortun J; Notterpek L
J Neurosci Res; 2005 Dec; 82(6):743-52. PubMed ID: 16273544
[TBL] [Abstract][Full Text] [Related]
9. [Molecular genetics of inherited neuropathies].
Takashima H
Rinsho Shinkeigaku; 2006 Jan; 46(1):1-18. PubMed ID: 16541790
[TBL] [Abstract][Full Text] [Related]
10. Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease.
Nobbio L; Vigo T; Abbruzzese M; Levi G; Brancolini C; Mantero S; Grandis M; Benedetti L; Mancardi G; Schenone A
Neurobiol Dis; 2004 Jun; 16(1):263-73. PubMed ID: 15207283
[TBL] [Abstract][Full Text] [Related]
11. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
Hanemann CO; Stoll G; D'Urso D; Fricke W; Martin JJ; Van Broeckhoven C; Mancardi GL; Bartke I; Müller HW
J Neurosci Res; 1994 Apr; 37(5):654-9. PubMed ID: 8028042
[TBL] [Abstract][Full Text] [Related]
12. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
[TBL] [Abstract][Full Text] [Related]
13. [Genetics of peripheral neuropathies and hereditary ataxias].
Palau F; Sevilla T
Neurologia; 1995 Dec; 10 Suppl 1():32-43. PubMed ID: 8838557
[TBL] [Abstract][Full Text] [Related]
14. Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot-Marie-Tooth disease).
Berger P; Niemann A; Suter U
Glia; 2006 Sep; 54(4):243-57. PubMed ID: 16856148
[TBL] [Abstract][Full Text] [Related]
15. Recessive, but not dominant, mutations in peripheral myelin protein 22 gene show unique patterns of aggregation and intracellular trafficking.
Liu N; Yamauchi J; Shooter EM
Neurobiol Dis; 2004 Nov; 17(2):300-9. PubMed ID: 15474367
[TBL] [Abstract][Full Text] [Related]
16. Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene.
Roa BB; Garcia CA; Suter U; Kulpa DA; Wise CA; Mueller J; Welcher AA; Snipes GJ; Shooter EM; Patel PI; Lupski JR
N Engl J Med; 1993 Jul; 329(2):96-101. PubMed ID: 8510709
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis in Japanese patients with Charcot-Marie-Tooth disease: DGGE analysis for PMP22, MPZ, and Cx32/GJB1 mutations.
Numakura C; Lin C; Ikegami T; Guldberg P; Hayasaka K
Hum Mutat; 2002 Nov; 20(5):392-8. PubMed ID: 12402337
[TBL] [Abstract][Full Text] [Related]
18. The "CMT rat": peripheral neuropathy and dysmyelination caused by transgenic overexpression of PMP22.
Niemann S; Sereda MW; Rossner M; Stewart H; Suter U; Meinck HM; Griffiths IR; Nave KA
Ann N Y Acad Sci; 1999 Sep; 883():254-61. PubMed ID: 10586250
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A).
Sereda MW; Meyer zu Hörste G; Suter U; Uzma N; Nave KA
Nat Med; 2003 Dec; 9(12):1533-7. PubMed ID: 14608378
[TBL] [Abstract][Full Text] [Related]
20. Abnormal Schwann cell-axon interactions in CMT neuropathies. The effects of mutant Schwann cells on the axonal cytoskeleton and regeneration-associated myelination.
Sahenk Z
Ann N Y Acad Sci; 1999 Sep; 883():415-26. PubMed ID: 10586265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]